Teladoc Health, Inc.
TDOC
$5.35
-$0.17-3.08%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 49.21% | -51.58% | 64.89% | -92.14% | -45.48% |
| Total Depreciation and Amortization | 20.25% | -1.34% | 4.79% | -13.92% | 0.16% |
| Total Amortization of Deferred Charges | -7.19% | -4.65% | 5.73% | 17.73% | -0.65% |
| Total Other Non-Cash Items | -70.68% | 107.03% | -73.42% | 85.75% | -14.25% |
| Change in Net Operating Assets | -82.92% | 78.46% | 133.23% | -476.86% | -25.60% |
| Cash from Operations | -11.61% | 8.57% | 474.36% | -81.47% | -22.03% |
| Capital Expenditure | -14.87% | -79.81% | 53.48% | 55.54% | -283.97% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | -2,292.22% | 98.93% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.24% | 48.32% | -3.22% | -137.90% | 20.44% |
| Cash from Investing | 29.56% | 18.39% | 51.57% | -315.83% | 4.83% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 100.00% | -- | -- | -- |
| Issuance of Common Stock | 113.35% | -25.72% | -9.49% | -59.14% | 96.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.02% | -- | -- | -- | 167.95% |
| Cash from Financing | 130.73% | 99.35% | -71,612.74% | -62.63% | 194.84% |
| Foreign Exchange rate Adjustments | 195.06% | -107.22% | 183.03% | 141.12% | -319.28% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 17.60% | 109.08% | -389.27% | -292.79% | -33.16% |